XML 36 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment and Geographic Information
12 Months Ended
Dec. 31, 2017
Segment and Geographic Information [Abstract]  
Segment and Geographic Information

15. SEGMENT AND GEOGRAPHIC INFORMATION

The Company evaluates reporting segments in accordance with FASB ASC 280, “Segment Reporting”. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers globally. Management considers all such sales to be part of a single operating segment. Revenue attributed to geographic areas is based on the location of the customers to whom products are sold.

Revenue by geographic area was as follows:







 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

2017

 

2016

 

2015

United States

 

$

138,387 

 

$

122,385 

 

$

102,212 

Europe

 

 

21,901 

 

 

19,772 

 

 

17,180 

Asia

 

 

13,616 

 

 

12,223 

 

 

9,510 

Other international

 

 

812 

 

 

729 

 

 

853 

Total international

 

 

36,329 

 

 

32,724 

 

 

27,543 

Total revenue

 

$

174,716 

 

$

155,109 

 

$

129,755 



United States revenue by product type was as follows:







 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

2017

 

2016

 

2015

Open-heart ablation

 

$

64,517 

 

$

58,050 

 

$

53,541 

Minimally invasive ablation

 

 

34,421 

 

 

31,169 

 

 

21,564 

AtriClip devices

 

 

37,281 

 

 

30,321 

 

 

24,377 

Total ablation and AtriClip devices

 

 

136,219 

 

 

119,540 

 

 

99,482 

Valve tools

 

 

2,168 

 

 

2,845 

 

 

2,730 

Total United States

 

$

138,387 

 

$

122,385 

 

$

102,212 



International revenue by product type was as follows:







 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

2017

 

2016

 

2015

Open-heart ablation

 

$

20,718 

 

$

20,189 

 

$

16,287 

Minimally invasive ablation

 

 

8,007 

 

 

8,065 

 

 

7,964 

AtriClip devices

 

 

7,251 

 

 

3,986 

 

 

2,868 

Total ablation and AtriClip devices

 

 

35,976 

 

 

32,240 

 

 

27,119 

Valve tools

 

 

353 

 

 

484 

 

 

424 

Total international

 

$

36,329 

 

$

32,724 

 

$

27,543 



The Company’s long-lived assets are located primarily in the United States, except for $957 as of December 31, 2017 and $931 as of December 31, 2016, which are located primarily in Europe.